The startup is being developed under the guidance of three medical experts: Natalia Rodriguez Jockovich, Mario Cabodi, and Rajan Dewar. They all have academic degrees in their respective fields and deep knowledge of health care.
The project is designed to transform medical services and improve the mechanics of testing patients for HPV.
What’s the value of Jane Diagnostics?
The technology optimizes searching for factors that influence the formation of cervical cancer. The advantage of this solution is the rapid delivery of a negative or positive test result. The platform is based on a unique development using hybrid paper-microfluidic technology.
The purpose of creating and releasing the product is to ensure that healthcare services are available to all population categories, regardless of location and status.
The speed of analysis processing is a JaneDX specialty. The mobility of the technology makes it possible to conduct tests even in “field” conditions, obtaining relevant results in less than an hour. In addition, even untrained healthcare workers can perform tests. Together, these advantages make it possible to detect serious diseases caused by HPV earlier and to diagnose women’s health problems more effectively.
Who can benefit from the JaneDX project?
Everyone whose activities are aimed at providing quality medical services. Healthcare institutions, medical device software development providers, mobile laboratories, and institutes, in tandem with JaneDX, can improve process efficiency and take their services to the next level.
The JaneDX solution belongs to the category of medical innovations and is designed to solve several pressing problems:
- availability of HPV testing services;
- speed of analysis of test results;
- accuracy of test results;
- quality of medical services;
- cost of health services.
DNA amplification and detection technology from JaneDX have the potential to transform the entire medical industry.
